Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: An interrupted time-series analysis

Oral third-generation cephalosporins (3GCs) are not recommended for use owing to their low bioavailability and the risk of emergence of resistant microorganisms with overuse. A standardized and effective method for reducing their use is lacking. Here, in a 60-month, single-institution, interrupted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Itoh, Naoya, Kawabata, Takanori, Akazawa, Nana, Kawamura, Daichi, Murakami, Hiromi, Ishibana, Yuichi, Kodama, Eiichi N., Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910666/
https://www.ncbi.nlm.nih.gov/pubmed/36758108
http://dx.doi.org/10.1371/journal.pone.0281518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910666/
https://www.ncbi.nlm.nih.gov/pubmed/36758108
http://dx.doi.org/10.1371/journal.pone.0281518

Ejemplares similares